Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Cincinnati Children's Hospital Medical Center
Cincinnati, Estados UnidosPublicacións en colaboración con investigadores/as de Cincinnati Children's Hospital Medical Center (17)
2024
-
Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis
Blood, Vol. 144, Núm. 8, pp. 873-887
-
Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries
Heart and Lung, Vol. 68, pp. 131-144
2022
-
Prognostic factors for patients with relapsed central nervous system nongerminomatous germ cell tumors
Pediatric Blood and Cancer, Vol. 69, Núm. 1
-
Src kinase as a potential therapeutic target in non-alcoholic and alcoholic steatohepatitis
Clinical and Translational Discovery, Vol. 2, Núm. 1
2021
-
Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis
Arthritis Care and Research, Vol. 73, Núm. 9, pp. 1264-1274
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
Rheumatology (United Kingdom), Vol. 60, Núm. 10, pp. 4568-4580
-
Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study
Arthritis and Rheumatology, Vol. 73, Núm. 2, pp. 336-346
2020
-
Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: Analysis by the Pharmachild Safety Adjudication Committee
Arthritis Research and Therapy, Vol. 22, Núm. 1
2019
-
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor
Cancer Cell, Vol. 36, Núm. 1, pp. 51-67.e7
-
American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus
Arthritis Care and Research, Vol. 71, Núm. 5, pp. 579-590
-
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
The Lancet Child and Adolescent Health, Vol. 3, Núm. 4, pp. 255-263
2018
-
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice
Blood Advances, Vol. 2, Núm. 19, pp. 2491-2504
2015
-
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
Leukemia, Vol. 29, Núm. 7, pp. 1458-1469
-
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Nature Medicine, Vol. 21, Núm. 6, pp. 555-559
2009
-
Prognostic factors and outcomes for osteosarcoma: An international collaboration
European Journal of Cancer, Vol. 45, Núm. 13, pp. 2367-2375